Rachel Newson
Principal Research Scientist, Global Patient Outcomes And Real World Evidence @ Eli Lilly and Company
About Rachel Newson
Rachel Newson is a Principal Research Scientist at Eli Lilly and Company, specializing in Global Patient Outcomes and Real World Evidence. With extensive experience in epidemiology and health research, she has held various roles in notable organizations, contributing to studies and models that support diabetes-related product launches.